Pharmaceutical Industry Information Portal

HomeNews

News

Binnopharm Group has increased export production at its Zelenograd site by almost three times

In the first quarter of 2025, the Zelenograd production site of Binnopharm Group increased its output of medicinal products for export by almost three times compared to the same period in 2024.

Pharmasyntez to launch the first innovative Russian medication to treat blood cancer (CML)

Vamotinib is about to be registered and put into civil circulation by Pharmasyntez, a Russian pharmaceutical company that aims to provide Russian patients with access to new and innovative medications.

GMP-inspections of veterinary manufacturers in the first quarter of 2025

The quarterly review provides information on the inspection of manufacturers of veterinary medicines for compliance with the requirements of the Good Manufacturing Practice (GMP)...

Binnopharm Group Successfully Places its Second Bond Issue of 2025 Worth 6 billion RUB

Binnopharm Group, one of Russia’s leading pharmaceutical companies, announced a successful placement of its second bond issue in the current year. The amount of...

Microgen has registered a new vaccine for children against tick-borne encephalitis in Belarus

The children's vaccine Encevir Neo for the prevention of tick-borne encephalitis, developed by SPA Microgen (part of the Nacimbio holding company of Rostec State...

Experts propose changes to the rules for regulating veterinary medicinal products in the EAEU

On February 25, a working meeting of experts was held at the Russian Union of Industrialists and Entrepreneurs (RSPP) to develop proposals for amending...
spot_img

Expert Articles

spot_img